InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
T+90 hit rate
67%
T+90 mean return
+19.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Burke Steven Keith, Vice-Président Senior et Médecin-Chef. Officer active across 1 company, notably Akebia Therapeutics, Inc.. In total, 15 reports have been recorded. Split: 0 buy · 11 sells. Total volume traded: €157k. History available since 31 August 2021. The latest transaction was filed on 3 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
7,144 shares@ US$1.838.0% of flowCommon StockSEC:0001562180-25-001997:0
194,900 shares0Common StockSEC:0001562180-25-000916:0
27,000 shares@ US$1.1518.3% of flowCommon StockSEC:0001562180-24-003948:0
7,169 shares@ US$1.586.7% of flowCommon StockSEC:0001562180-24-002020:0
8,367 shares@ US$1.527.5% of flowCommon StockSEC:0001562180-24-001993:0
202,200 shares0Common StockSEC:0001562180-24-000970:0
63,567 shares@ US$1.06839.8% of flowCommon StockSEC:0001562180-23-004254:0
6,613 shares@ US$0.87753.5% of flowCommon StockSEC:0001562180-23-002199:0
7,539 shares@ US$0.81323.7% of flowCommon StockSEC:0001562180-23-002040:0
196,200 shares0Common StockSEC:0001562180-23-000830:0
1,147 shares@ US$0.36250.3% of flowCommon StockSEC:0001562180-22-006402:0
200,000 shares0Common StockSEC:0001562180-22-004031:0
7,400 shares@ US$2.15480.0050% mcap74.1% of flowCommon StockSEC:0001562180-22-002165:0
1,042 shares@ US$2.830.0009% mcap13.0% of flowCommon StockSEC:0001562180-21-005744:0
1,042 shares@ US$2.831.6% of flowCommon StockSEC:0001562180-21-005744
15 of 15 declarations
About Burke Steven Keith
Steven Keith Burke is Senior Vice President and Chief Medical Officer at Akebia Therapeutics, Inc. He oversees the company's medical and clinical initiatives, ensuring innovation and quality of care. Burke plays a vital role in developing new treatments and therapies.
